Dr. Alexander Decruyenaere presented the poster Optimal treatment duration in metastatic renal cell carcinoma patients responding to immune checkpoint inhibitors: should we treat beyond two years? Dr.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback